GENEO, positive finance

GENEO's raison d'être is to make positive finance available to the real economy. Our business is to invest in and support growth SMEs and SMIs in their long-term development projects.

Our approach

Participate in your development capital and family or managerial transmission projects.

Giving each generation
the means to achieve its ambitions

GENEO's raison d'être is to make positive finance available to the real economy. Our business is to invest in and support growth SMEs and SMIs in their long-term development projects.

How we accelerate your growth?

GENEO conviction

Our investment vehicles

Positive finance, sustainable growth, increasing human capital: this is GENEO's ambition for our Builder entrepreneurs. To support them in their growth, GENEO invests and invests with :

→ GENEO Capital: our investment vehicle that provides SMEs and SMIs with the financial and human resources to accelerate their growth.

→ GENEO Mezzanine: our quasi-equity investment vehicle, whose rate is indexed to impact indicators.

→ Obligations Relance: our one-off financing in Bonds, the rate of which is indexed to a CSR criterion. A France Relance scheme.

Our team

When we invest in you, we invest ourselves!

At GENEO, we believe that diversity and teamwork generate performance. Our team is multidisciplinary, mixed and made up of personalities committed to serving the GENEO community. Its organisation is designed to maximise the effectiveness of the GENEO model in terms of differentiation, value creation in investments, and synergies within the GENEO Community.

Key figures

27 companies invested

since 2019 in a positive impact dynamic

220+ families and entrepreneurs

committed to a Community that makes sense of finance

70+ experts

mobilised to support the realisation of the Growth Logs

€550M+ managed

with patience and determination

GENEdico

Evergreen -

A term used in botany to signify the persistent nature of certain trees that do not lose their leaves. In finance, this "persistence" is expressed in duration. GENEO Capital Entrepreneur is an evergreen investment company: the life of our investments is potentially unlimited. Our support extends as long as necessary.

Our news

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
Otego announces a new capital transaction with its historic investors to support its growth, continue to develop its responsible commitments and strengthen its international presence.

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
The Epiktet group is initiating its diversification into the home care sector with the acquisition of Amelis, a former subsidiary of Sodexo Home Care from the Halifax fund

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.
Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Manager

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.

See all news

They trust us

Follow GENEO

#geneocapitalentrepreneur the